Abdominal migraine by Angus-Leppan, H et al.
CLINICAL UPDATES
Abdominal migraine
Heather Angus-Leppan consultant neurologist 1  2  3, Defne Saatci paediatric trainee 4, Alastair Sutcliffe
professor of general paediatrics and honorary consultant paediatrician 4, Roberto J Guiloff consultant
neurologist and professor of neurology 5  6
1Clinical Neurosciences, Royal Free London NHS Foundation Trust, London NW3 2QG, UK; 2Institute of Neurology, University College London;
3Centre for Research in Primary and Community Care, University of Hertfordshire, Hatfield, UK; 4University College London and Great Ormond
Street Institute of Child Health, University College London; 5Imperial College London; 6Faculty of Medicine, University of Chile, Santiago, Chile
What you need to know
• Abdominal migraine is episodic central
abdominal pain occurring with other features
of migraine and associated with other episodic
syndromes (particularly cyclical vomiting and
migraine limb pain)
• Abdominal migraine usually starts in
childhood, though it may occur in adults,
commonly with a family history of migraine
• The person is well between episodes with a
normal physical examination and
developmental milestones
• Abdominal migraine is a positive clinical
diagnosis and requires no further investigation
once “red flags” are excluded
• To manage abdominal migraine, provide an
explanation of the diagnosis and discuss
available acute and preventive treatments with
the patient and family
Abdominal migraine is an important, common, and
under-recognised cause of recurrent abdominal pain in children.
It may be associated with, or followed by, other forms of
migraine, and it predicts adult migraine.1-4A positive diagnosis
of abdominal migraine allows appropriate management and
avoids unnecessary investigations and incorrect treatments.3 5
Although the evidence base is limited, acute and preventive
treatments are available. This article highlights the diagnosis
and management of abdominal migraine for non-specialists.
Sources and selection criteria
We performed a Medline search and search of
Cochrane Collaboration and Clinical Evidence
databases, using the terms “abdominal migraine,”
“episodic (periodic) syndromes,” “childhood
migraine,” “recurrent abdominal pain,” “functional
abdominal pain.” We gathered evidence on the
treatment of childhood migraine and childhood pain
from the Cochrane Collaborations, particularly with
regard to safety of acute treatment of migraine in
children. Guidelines of the Rome Foundation,
International Headache Society and North American
Society for Pediatric Gastroenterology, Hepatology,
and Nutrition informed discussion of definitions and
management. These sources were supplemented
by our personal archive of references, cited
references from these, and discussions with other
experts.
What is abdominal migraine?
Abdominal migraine is a functional disorder in the broad sense
(a disorder without recognised structural or biochemical
diagnostic abnormality6). It is an episodic syndrome on the
migraine spectrum1 7 and consists of intermittent central
abdominal pain severe enough to interfere with normal
activities.2-8 The pain comes with migrainous features including
sensory disturbance (photophobia, phonophobia), anorexia,
nausea, vomiting, and pallor.7 8 Crucially, the patient is
symptom-free and well between episodes, with a normal
physical examination, stable body mass index, and expected
developmental milestones. These elements are agreed by
consensus diagnostic criteria for abdominal migraine (the
International Classification of Headache Disorders
(ICHD-3beta)7 and the Rome IV Classification of
Gastroenterology Disorders9) and by earlier descriptions.8 10
Other aspects of the diagnosis are debated.4-12 Headache as an
accompanying feature is omitted by one classification,7
excluding up to 70% of cases.3-13 The consensus classifications
require an arbitrary number of episodes, and at least two
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migrainous features.7 9 The stipulated duration of one9 or two7
hours misses briefer episodes,4 as found in a hospital study in
India5 and in accord with the authors’ experience. It is worth
being aware of a possible diagnosis of abdominal migraine in
those with some but not all consensus criteria.5-15 Patients often
have other episodic syndromes, excluded from both consensus
criteria.1Boxed Text on page 2 Box 1 provides a practical
definition based on current consensus diagnostic criteria,
published evidence, and the authors’ experience.
Box 1Recommended pragmatic clinical definition of
abdominal migraine*
• Episodic central abdominal pain, usually
lasting >1 hour
• Episodes interfere with normal activity
• Episodes occur with one or more of pallor,
anorexia, nausea, vomiting, photophobia,
headache, or are associated with other
episodic syndromes (particularly cyclical
vomiting and migraine limb pain)
• Person is well between episodes
• Normal physical and developmental
examination
* Adapted from definitions of Symon and
Russell,8 ICHD-3beta,7 and Rome IV9 and
published studies2-15
How common is abdominal migraine?
Prevalence depends on definition, awareness, and setting in the
absence of an objective diagnostic marker. In two British studies
of children, population prevalence of abdominal migraine was
4.1% and 2.4% using the 1986 definition.2 13 Using the Rome
III diagnostic criteria,16 prevalence was 9.2% in a US
questionnaire study of the mothers of 949 children.17 Population
prevalence in a study of British schoolchildren peaked at 6-12
years, highest at 9% at 12 years, and falling to 1% at 14 years,2
with a female:male ratio of 1.6:1.2
What triggers and relieves abdominal
migraine?
Stress, tiredness, travel, missed meals, and change in routine
may trigger abdominal migraine,2 3 as for all migraine.
Sometimes, triggers may be confused with premonitory
symptoms (symptoms preceding or forewarning of a migraine
episode).7 For example, bright light or low mood may seem to
trigger an episode, when, in fact, photophobia and mood change
are recognised premonitory symptoms.18 Relieving factors for
abdominal migraine, as for other migraines, are rest (in 88% of
patients), sleep (in 64%), and analgesia (in 38%).2
How do I diagnose abdominal migraine?
Typically a child with abdominal migraine presents to general
practice or an emergency department with the features outlined
in Boxed Text on page 2box 1. The challenge is to distinguish
it from organic and other functional causes of recurrent
abdominal pain by confirming positive features and excluding
“red flags” (⇓). “Red flags” suggest organic causes of abdominal
pain (⇓), and so refer these children for an immediate expert
opinion.22 Assessment is particularly difficult in children less
than 2 years old, who may not be able to explain or point to the
pain. In them, abdominal pain often manifests with non-specific
features such as inconsolable crying and pulling up of the legs.
Patients with abdominal migraine often have a personal or
family history of other types of migraine, similar undiagnosed
episodes, or other episodic syndromes.3 4
Examination—including vital signs, temperature, and urine
analysis—is normal apart from vasomotor changes (pallor, dark
rings under the eyes).3 4 Urine analysis is an important part of
the physical examination, as patients with diabetic ketoacidosis
or urinary tract infection may present with abdominal pain. If
a child with previously diagnosed abdominal migraine presents
again it may suggest that the child or carer is concerned there
is something different about the episode. In this situation fully
re-assess, especially if there are new or atypical symptoms or
signs, as they could have a second acute diagnosis.
Other than abdominal migraine, neurological causes of
abdominal pain are rare. In abdominal epilepsy, the pain is
usually brief (seconds to minutes) and associated with altered
awareness, and sometimes followed by a tonic-clonic seizure.23
Consensus guidelines suggest that children with a firm clinical
diagnosis of abdominal migraine require no further
investigations.9-24
What causes abdominal migraine?
Specific changes to the gut-brain axis, vascular dysregulation,
changes in the central nervous system, and genetic factors have
been suggested as the cause of abdominal migraine.25 It is not
known why some people are vulnerable to this interaction
between the central nervous system and the richly innervated
gut, and whether this links with the trigemino-vascular system,
which plays a major role in migraine headache.26 27 No studies
suggest vasospasm of small gut vessels as the cause of the
periumbilical pain, but regional or central changes28 29 in blood
flow may be important, as they are for other forms of migraine.26
The strong familial incidence in abdominal and other migraine
suggests an important genetic role,30 particularly for mutations
involving cell membrane transport (channelopathies).31 32
What other conditions is abdominal
migraine associated with?
From population studies, 70% of those with abdominal migraine
have current or previous migraine headache with or without
aura.10 Patients with abdominal migraine often have other
concurrent or previous episodic syndromes (60% of 84 patients3
and 30.6% of 1134 patients1 in hospital series), particularly
cyclical vomiting (66-76%)3-36 and migraine limb pain.1-38 Other
possible associations are benign paroxysmal vertigo,39 40 benign
paroxysmal torticollis,1 31 infantile colic,41 42 Raynaud’s
disease,43 44 and hypermobility45 46 (see ⇓).
Is abdominal migraine linked to mental
health?
Avoid assuming that abdominal pain in children without
demonstrable pathology has a psychogenic basis.3-47 Links with
anxiety,48 49 depression,48-50 psychosocial difficulties,49 51and
abuse52 are postulated. Some studies49-54 and expert opinion12-57
equate association and causality. Some studies are in
uncontrolled52 or unrepresentative populations,52 have only
pain-free controls,50 group all functional abdominal pain as a
homogenous diagnosis,49-58 or underestimate population
variability of paediatric anxiety and depression (3.8-11%
depending on definitions, age, severity, and setting59). Controlled
studies show that pain is associated with psychological distress,
in children, adults, and families whatever the cause60 61 or site.62
Levels of depression and emotional adjustment were similar in
children with functional abdominal pain and pain-free controls
with minor illnesses.63 Mood change as a premonitory symptom
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or postdrome is recognised in outpatient studies of paediatric
migraine,64 65 but there are no specific data on prevalence in
abdominal migraine.
What happens to children with abdominal
migraine as they grow up?
Children with abdominal migraine or other episodic syndromes
usually have an excellent prognosis with no neurological or
developmental deficits.10 A longitudinal study in 54
schoolchildren showed the clinical diagnosis of abdominal
migraine was robust (using adapted criteria of Symon and
Russell8). It resolved in 61% at 8-10 year follow-up.10 The
prevalence and outcome of abdominal migraine in adults is
unknown, with evidence limited to case reports and small
series.11-68
How are children with abdominal migraine
managed?
General and psychosocial approaches
A clear diagnosis3 and explanation of the condition to the patient
and family is essential (see information sheets in appendix on
bmj.com).2 3 In an observational clinic study, 60% of patients
had parents with the same condition who were also relieved to
understand it.3 Labelling abdominal migraine as medically
unexplained69 or psychogenic pain49 70 may exacerbate depression
and anxiety in the child and parents. Missing the diagnosis5 14
led to unsuccessful surgery (mainly appendicectomy) in 4%3
and 5%5 of patients with abdominal migraine in British and
Indian hospital series.
The biopsychosocial model of pain and symptom management
emphasises a holistic view of the patient’s life.6 9 Cognitive
behavioural therapy improved functional abdominal pain in a
case controlled series,71 but there are no specific data for
abdominal migraine. Dietary treatments and elimination diets
are unproved.11 Anecdotally, understanding or avoidance of
triggers (such as acute emotional stresses, missed meals, and
sleep loss) is helpful.3-22 Acute symptoms resolve in >80% of
patients with rest in a dark quiet room and simple analgesia (see
Boxed Text on page 3box 2, and ⇓ on bmj.com).2
Box 2Management strategies for abdominal migraine
(see ⇓ on bmj.com for supporting evidence)
General
• Explanation and education of patient and
family (avoid triggers, regular lifestyle)2 3*
Acute
• Rest in dark, quiet room*
• Simple analgesics such as paracetamol 15
mg/kg, ibuprofen 10 mg/kg*
• Sumatriptan—10 mg intranasal (triptan,
serotonin agonist)*
Preventive treatment
• Pizotifen (serotonin agonist) 0.25 mg twice
daily as syrup*
• Propranolol (β blocker) 10-20 mg twice or
three times daily
• Cyproheptadine (antihistamine) 0.25-0.5
mg/kg daily as syrup
• Flunarazine (calcium channel blocker) 5-7.5
mg/day
• Sodium valproate (anti-epileptic) 500 mg three
times daily intravenous—in hospital
• Dihydroergotamine (ergot) 0.5 mg intravenous,
further doses possible (up to mean total 7-9
mg over several days)—in hospital
*Treatments can be given in primary care.
Pharmacological approaches
The evidence for pharmacological treatment of abdominal
migraine is limited. In studies of paediatric migraine headache,
resolution rates of up to 66% are reported with placebo
treatment,85 so high quality randomised controlled trials are
needed to confirm efficacy of active treatments.86 Pizotifen is
the only medication meeting this standard for abdominal
migraine.87⇓ on bmj.com summarises current evidence for
treatments. Acute treatments, and if needed, prevention with
pizotifen, may be managed in primary care, and will be effective
in most patients. Expert advice is recommended for other
medications because data are limited (cyproheptadine,
propranolol, flunarazine, sodium valproate, dihydroergotamine)
or absent (amitriptyline, topiramate) regarding use for abdominal
migraine. It is unknown whether evidence on acute76 or
preventive management88 of childhood migraine headache can
be extrapolated to abdominal migraine. The only evidence for
treatment of adult abdominal migraine is from case reports.68
Education into practice
• Does this article improve your confidence in
making a positive diagnosis of abdominal
migraine in those with recurrent abdominal
pain? What might you ask or do differently?
• How might you better explain or offer advice
to patients and families with abdominal
migraine?
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Useful resources
• American Migraine Foundation* https://
americanmigrainefoundation.org/
understanding-migraine/abdominal-migraine/
• Migraine Action* www.migraine.org.uk/
• The Migraine Trust* https://www.migrainetrust.
org/
• Patient. Migraine in children* https://patient.
info/doctor/migraine-in-children
• The International Headache Society www.ihs-
headache.org
• The Rome Foundation www.
theromefoundation.org/
• The American Headache Society https://
americanheadachesociety.org/
*Includes resources for patients and families
How patients were involved in the creation of this
article
Parents and a patient with abdominal migraine
reviewed the information sheets and read the article,
commenting on sections which they did not feel were
clear (the initial description of abdominal migraine
and how the diagnosis was made). These comments
were used to improve the manuscript. The patient
drew the original sketch for ⇓.
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Tables
Table 1| Red flag symptoms associated with childhood abdominal pain (adapted from Rome III16 and Rome IV9 classification)
Common associated conditionsRed flag symptom
Acute
Any acute worsening pathologyFeatures of dehydration or shock*
Diabetic ketoacidosisThirst, polyuria
“Surgical” (appendicitis, volvulus, intussusception)Localised pain with tenderness or guarding
Infection (gastroenteritis† mesenteric adenitis)Fever
ObstructionVomiting bile
Upper gastrointestinal bleedVomiting blood
Gastrointestinal bleed, infectionBloody stool
Gastroenteritis†Change in bowel habits (diarrhoea)
Urinary tract infectionDysuria, haematuria
Testicular torsionPain that radiates to the groin
Chronic or recurrent
Tonsillitis, peritonsillar abscessOdynophagia
Reflux, developmental delay, metabolic, geneticDysphagia
IBD, coeliac disease, malignancyPersistent right upper or right lower abdominal pain
Malignancy, storage diseasesAbdominal mass
Reflux, cow’s milk protein allergy, malignancyPersistent vomiting
IBD, coeliac disease, malignancy, metabolic, geneticWeight loss
Infection, IBD, malignancyFever, night sweats
IBD, coeliac disease, cow’s milk protein allergy, malignancyChange in bowel habit (bloody stool or chronic diarrhoea)
IBD, malignancy, metabolic, geneticGrowth failure and delayed puberty
IBD, coeliac diseasePerianal abnormalities (fistulae, fissures, skin tags)
IBDArthritis or family history of IBD
*
NICE 200921 provides a table of progressive features of dehydration and shock.
†
Acute gastroenteritis needs urgent expert opinion if other red flags present.
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Table 2| Treatment strategies for abdominal migraine in children
Grade of
evidence†72Safety* and availabilityMain resultsDuration
Outcome
measuresNo of participantsStudy typeIntervention
General‡§
Level 4No adverse events100% improvement,
not further specified
Not specifiedImprovement, not
otherwise specified
112 with abdominal
migraine and/or
cyclical vomiting
(defined in Boxed Text
on page 2box 1)
Case series in UK
paediatric clinic
aged 18 months to
15 years3
Explanation and
education of patient
and family (avoid
triggers, regular
lifestyle)2 3
Acute treatment‡
Level 3No adverse events88% (51/58)
resolved
Not specifiedResolution of acute
episode of
abdominal migraine
58 with abdominal
migraine (Symon and
Russell definition8)
Observational
study of random
sample of Scottish
schoolchildren
aged 5-15 years2
Rest in dark, quiet
room
Level 3
(safety
evidence is
level 1 or 2)*
No adverse events in
this study.
No difference between
acute ibuprofen,
paracetamol and
placebo in adverse
38% (22/58)
resolved
Acute, not
further
specified
Resolution of acute
episode of
abdominal migraine
As aboveAs above2Simple analgesics
such as
paracetamol 15
mg/kg, ibuprofen 10
mg/kg
events in meta-analysis
of children with pain or
fever.73 Paracetamol safe
at recommended doses,
hepatotoxic in overdose74
Level 4No adverse events in
this study.
Increased risk of minor
adverse events in
meta-analysis of
paediatric migraine.76*
Avoid overuse77 (may
cause rebound
symptoms**)
Licensed >12 years
(UK),76 >6 years (US)78
Acute pain
responded (n=2)
Acute,
repeated over
2 years
Resolution of acute
episode of
abdominal migraine
12 year old girl with
abdominal migraine
(Rome III definition16).
9 year old girl with
abdominal migraine
(Boxed Text on page
2box 1 definition)
Case reports,
Japanese
paediatric clinic75
Sumatriptan 10 mg
intranasal (triptan,
serotonin agonist)¶
Preventive treatment (consider if >2 attacks/month or major impact despite acute treatment)
Level 1 or 2Adverse events: mild
drowsiness, weight gain
(1.25 kg v 0.38 kg,
P=0.035). Available
worldwide but not
licensed in US
Improvement: fewer
days (4.29 v 12.5,
P<0.005); severity
lower (7.29 v 23.5,
P<0.005); index of
misery lower (25.43
v 81.5, P<0.007)
2 months in
each crossover
arm
Days affected.
Index of severity.
Index of misery
(severity × duration)
14 patients, aged 5-14
years with abdominal
migraine (Symon and
Rusell definition8)
Randomised,
double blind,
placebo controlled,
crossover trial, UK
paediatric clinic79
Pizotifen (serotonin
agonist) 0.25 mg
twice daily as
syrup‡ ¶ ††
Level 3 or 4Adverse events:
shortness of breath
(1/24), headache (1/24),
drowsiness (1/24).
Asthma is
contra-indication. Expert
guidance recommended
75% (18/24)
excellent, 8% (2/24)
fair, 17% (4/24) poor.
Two responded to
cyproheptadine.
Mean (SE) No of
episodes in
Duration as
required: 3-6
months for
11/24, 3 years
for 13/25
Responses: graded
as excellent
(pain-free), fair
(improved but not
resolved), or poor
(no response). No
of episodes in
preceding 6 months
24 patients with
abdominal migraine
(Boxed Text on page
2box 1 definition)
Retrospective
clinic case note
review in US
paediatric
gastroenterology
clinic, 3-15 years
old15
Propranolol (β
blocker) 10-20 mg
two or three times
daily
preceding 6 months
versus 6 months’
treatment
5.4 (0.6) versus 1.0
(0.3) in 6 months’
treatment
Level 3 or 4Adverse events:
drowsiness (1/12),
weight gain (1/12).
Expert guidance
recommended
33% (4/12) excellent,
50% (6/12) fair, 17%
(2/12) poor.
Mean (SE) No of
episodes in
preceding 6 months
Duration as
required: 2-11
months
As above12 patients with
abdominal migraine
(Boxed Text on page
2box 1 definition)
As above15Cyproheptadine
(antihistamine)
0.25-0.5 mg/kg daily
as syrup‡‡
5.8 (2.1) versus 1.3
(0.5) in 6 months’
treatment
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Table 2 (continued)
Grade of
evidence†72Safety* and availabilityMain resultsDuration
Outcome
measuresNo of participantsStudy typeIntervention
Level 3Expert guidance
recommended
Frequency reduction
61%, duration
6-24 months
(mean 13
months)
Percentage
reduction in
frequency and
duration
10 patients with
abdominal migraine
Uncontrolled trial,
US paediatric
clinic80
Flunarazine
(calcium channel
blocker) 5-7.5
mg/day††
reduction 51%
(headache reduction
60%)
Level 4Adverse events: weight
gain (1/2).
Expert guidance
recommended
Episodes resolvedEpisodic
treatment
when other
treatments
including
sumatriptan
failed
Cessation of
refractory episode
and associated
behavioural
disturbance
2 girls, 12 and 17
years old, with
intractable abdominal
migraine (Russell et al
definition10 82)
Case studies, in
US paediatric
hospital81
Sodium valproate
(antiepileptic) 500
mg three times daily
intravenous¶
Level 4No significant adverse
events
Expert guidance
recommended
5/6 respondersEpisodic
treatment
Cessation of
refractory episode
Time to next
episode
6 patients, 13-19
years, intractable
abdominal migraine,
unresponsive to
amitriptyline,
verapamil, topiramate,
sodium valproate
Case series,
US hospital (joint
gastroenterology,
neurology and
autonomic
departments83
Dihydroergotamine
(ergot) 0.5 mg
intravenous, further
doses (mean 7-9 mg
total over several
days) ¶ ‡‡ §§
*
Safety derived from abdominal migraine studies and other studies in paediatrics.
†
Evidence grades 1-5 (highest to lowest).
‡
Treatments can be given in primary care.
§
See information leaflets in appendix on bmj.com.
¶
Caution in females of childbearing age.
**
Medication overuse in children: acute analgesics >3 days/month and migraine-specific drugs, especially triptans, >9 times/month.7-84
††
Availability limited in some parts of world.
‡‡
Little used in some parts of world.
§§
Not licensed for children in UK.
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Figures
Schematic approach to managing abdominal migraine (adapted from Rome III,16 19 Rome IV9 and ICHD-3 classifications,7
and Quek, 201520)
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A patient’s view of the associations of abdominal migraine and level of evidence for these
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